USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/17379
Full metadata record
DC FieldValueLanguage
dc.contributor.authorStavinskaia, Liudmila
dc.date.accessioned2021-06-06T14:27:14Z
dc.date.available2021-06-06T14:27:14Z
dc.date.issued2018
dc.identifier.citationSTAVINSKAIA, Liudmila. Hormone replacement therapy used for correction of menstrual dysfunction associated with liver pathology. In: Buletin de perinatologie. 2018, nr. 3(79) (supliment), pp. 7-8. ISSN 1810-5289.en_US
dc.identifier.issn1810-5289
dc.identifier.urihttps://mama-copilul.md/images/buletin-perinatologic/BP_2018/3_2018_supliment.pdf
dc.identifier.urihttp://repository.usmf.md/handle/20.500.12710/17379
dc.descriptionObstetrics and Gynaecology Department No. 2, State University of Medicine and Pharmaceutics «Nicolae Testemitanu», Republic of Moldova, Al VI-lea Congres Național de Obstetrică și Ginecologie cu participare internațională, 13-15 septembrie 2018, Chișinău, Republica Moldovaen_US
dc.description.abstractThe problem of viral hepatitis and menstrual dysfunctions stays present, is determined by the high incidence and severity of physiopathological abnormalities, specific to these associations. In the Republic of Moldova, 9% of the population are chronic carriers of HVB, HVC affects 1.5-5% of the population. The purpose of this work was to study the therapeutic effect of hormone therapy in women with menstrual dysfunctions caused by chronic viral hepatitis. Materials and methods: The controlled randomized study evaluated the treatment results of 80 patients with menstrual dysfunctions in association with liver pathology, randomly picked out from 319 women suffering from chronic viral hepatitis. The selection of the hormonal therapy was made depending on the menstrual irregularities, hormonal profile and results of the genitals sonography: o 1st group (26 patients) – hepatoprotectors, o 2nd group (23 patients) – Didrogesteron 10 mg (Duphaston) + hepatoprotectors, o 3rd group (31 patients) – Etradiol 2mg + Didrogesteron 10 mg (Femoston) + hepatoprotectors. The control group included 15 healthy women of reproductive age with normal menstrual cycle. Results: The examined patient’s age varied between 18 and 40 years, mean age - 26.0±5 years. Bilirubin level in patients with HVB was 3 times higher compared with the control group but in mix-hepatitis -10 times. Transaminases were elevated 10-40 times, especially in mixed viral hepatitis. Alkaline phosphatase (27.81 ± 1.3 UI/l), prothrombin, total protein, and albumin were considerably decreased. Similar changes have been observed in cholesterol level (dropped till 2.60±0.21 mmol/l) and β-lipoprotein (195.0 ± 25.3 Un), which are evidently decreased in all patients with all types of viral hepatitis. Regular menstrual cycle was present only in 7.5 ± 2.48.en_US
dc.language.isoenen_US
dc.publisherInstituţia Medico-Sanitară Publică Institutul Mamei și Copiluluien_US
dc.relation.ispartofBuletin de perinatologie: Al VI-lea Congres Național de Obstetrică și Ginecologie cu participare internațională, 13-15 septembrie 2018, Chișinău, Republica Moldovaen_US
dc.subjectmenstrual dysfunctionsen_US
dc.subjecthormone therapyen_US
dc.subjectchronic viral hepatitisen_US
dc.titleHormone replacement therapy used for correction of menstrual dysfunction associated with liver pathologyen_US
dc.typeOtheren_US
Appears in Collections:Buletin de Perinatologie Nr. 3(79) 2018 supliment

Files in This Item:
File Description SizeFormat 
Stavinskaya_HORMONE_REPLACEMENT_THERAPY_USED_FOR_CORRECTION_OF_MENSTRUAL_p.7_8.pdf170.13 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback